Keystone Conference on Cancer Immunotherapy
March 2025
Quebec City, Canada
Grant attended the Keystone Conference on Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations
- “Leveraging 53BP1 DNA Repair to Enhance CART cell Therapy in Solid Tumors", Grant Dawson
SITC Spring Scientific Conference
March 2025
Tuscon, AZ
- "Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response”, Jessica Kelliher
- "CD28 Co-stimulation Induces PCK2 to Support T Cell Effector Function in Metabolically Hostile Environments”, Thomas Williams
SRD Awards
March 2026
Best Overall, WPRCI Awards, Graduate Degree-Seeking Students
- 1st Place, Sydnye Shuttleworth
- 3rd Place, Katie Cruse
Best Overall, Little Rock Campus, Graduate Degree-Seeking Students
- 3rd Place, Sydnye Shuttleworth
3-Minute Thesis Competition (Little Rock)
- 1st Place, Katie Cruse
UAMS Student Research Day
March 2026
- "Proteome turnover dynamics analysis identifies RNF-166 as a critical E3 ubiquitin ligase driving T cell persistence”, Sydnye Shuttleworth
- "Leveraging 53BP1 DNA Repair toCombat T Cell Exhaustion in Glioblastoma Multiforme", Grant Dawson
- "CD28 Co-stimulation InducesPCK2 to Support T Cell EffectorFunction in Metabolically HostileEnvironments", Thomas Williams
- "Donor-intrinsic Proteomic Programs Shape CAR-T Cell Persistence Across a Longitudinal Killing Assay", Katie Cruse
Travel Award
February 2026
Banff, AB, Canada
Sydnye Received a Travel Award for Keystone Symposia Meeting: The Ubiquitin Family in Biology and Disease
Mentor Award
December 2025
Brian Received a Mentor Award
Outstanding Achievement Award
December 2025
Sydnye received an Outstanding Achievement Award from Graduate School
Peggy Epes Joins the Koss Lab
December 2025
SITC 2025
November 2025
40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2025) National Harbor, MD
- “ATF6 activation promotes ICB response in melanoma”, Brian Koss
- “Proteome turnover dynamics analysis uncovers E3 ligases that enhance T cell persistence during exhaustion”, Sydnye Shuttleworth
- "Engineering EZH2-Inhibitor Resistant CAR-T Cells to Preserve Function for Combination Therapy”, Daniel Fil
- "Donor-intrinsic Proteomic Programs Shape CAR-T Cell Persistence Across a Longitudinal Killing Assay”, Katie Cruse
- "Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response”, Jessica Kelliher
- CD28 Co-stimulation Induces PCK2 to Support T Cell Effector Function in Metabolically Hostile Environments”, Thomas Williams
